Hook & thesis
Oracle has been punished hard: the stock plunged from a $345 peak in 2025 to the mid-$150s today, even though the business is still growing and producing high-quality profits in its core software franchises. The price collapse has partly reflected one-time and transitional factors - heavy capital spending for cloud data centers that pushed free cash flow negative and temporarily increased leverage - rather than a permanent impairment of Oracle's franchise.
We think the market is beginning to price that distinction. With the shares at $159.70, strong operating metrics (17% reported revenue growth to roughly $67B, 36% net income growth, and 75% cloud infrastructure revenue growth) and a massive contracted backlog that gives revenue visibility, Oracle offers an asymmetric risk-reward for patient longs. This is a trade idea to lean into that unwinding: entry at $159.70, stop at $140.00, target $240.00 over a long-term (180 trading days) horizon.
What Oracle does and why it matters
Oracle sells enterprise applications, infrastructure technologies and associated services across cloud and on-premise deployment models. Its segments - Cloud and License, Hardware, and Services - give it breadth: software and cloud subscriptions provide high-margin recurring revenue, while hardware and services round out enterprise deals. Management reports a large contracted backlog that underpins revenue visibility and large enterprise renewals.
Why investors should care: Oracle sits at the intersection of two durable themes. First, enterprise software customers are still migrating to cloud-hosted stacks, and Oracle has shown strong growth in cloud infrastructure and cloud application revenue. Second, large enterprises value integrated stacks and long-term support contracts - which help maintain margins and customer stickiness. Those strengths should matter to valuation as capital spending normalizes and free cash flow recovers.
Numbers that support the setup
| Metric | Value |
|---|---|
| Current price | $159.70 |
| Market cap | $457.3B |
| Enterprise value | $555.6B |
| Reported revenue growth | 17% to ~$67B |
| Net income growth | 36% |
| Cloud infrastructure revenue growth | 75% |
| P/E (trailing) | ~27 |
| EV/EBITDA | ~17.5 |
| Free cash flow | -$23.69B |
| Dividend | $0.50 quarterly (yield ~1.26%) |
Valuation framing
At a market cap of roughly $457.3B and an enterprise value near $555.6B, Oracle trades at a trailing P/E near 27 and EV/EBITDA around 17.5. Those multiples reflect the market's concern about near-term cash flow and debt after aggressive data-center spending. Put differently, the market is pricing some permanence into the cash-flow impairment.
I find that excessive. Oracle reported strong revenue and net-income growth alongside high ROE (roughly 40%), which argues that the core software franchises remain profitable and competitive. If cash flow reverts as planned when capex moderates and utilization of new data centers rises, multiples could re-rate meaningfully. The company also carries a large contracted backlog that should support revenue visibility and downside protection to short-term demand shocks.
Technical and positioning note
Technically, momentum indicators are constructive: the 10- and 20-day SMAs sit near $148, the 50-day SMA is about $139.84, and RSI is around 61 with a bullish MACD histogram. Short interest has been modest historically and recently hovers around 47.8M shares on some settlement dates, suggesting limited crowded short risk should a positive catalyst appear.
Trade plan - actionable entry, stop, target
We recommend a long trade with the following parameters:
- Entry: $159.70 (current price)
- Stop loss: $140.00
- Target: $240.00
- Horizon: long term (180 trading days) - roughly 6 months. This horizon gives time for the company to report Q3 results (expected 09/10/2026) and for data-center utilization and free cash flow to begin normalizing.
Rationale: Entry at the current market price captures early-stage mean reversion and allows investors to participate if cash flow trends and margins recover over the next several quarters. The $240 target is a conservative re-rating toward historical multiple ranges relative to current fundamentals, still well below the 2025 peak of $345. The $140 stop limits downside to identifiable technical and fundamental stress points: a sustained breakdown below the 50-day range and further deterioration in cash-flow guidance or backlog realization.
Catalysts to watch
- 09/10/2026 - Q3 earnings: guidance and commentary on data-center utilization and capex cadence.
- Cash-flow inflection: any quarter showing materially improved free cash flow or lower-than-expected incremental capex.
- Backlog conversion: disclosures showing the $638B contracted backlog converting into bookings and recurring revenue.
- Large enterprise deals or renewed multi-year contracts that signal sticky revenue and margin resilience.
Risks and counterarguments
There are several legitimate reasons the stock is depressed and why the trade can fail. Be explicit about those risks before committing capital.
- Cash-flow risk: Free cash flow is negative (about -$23.69B reported). If data-center spending continues or utilization ramps slower than planned, cash flow could remain impaired longer, keeping multiples depressed.
- Leverage and balance-sheet risk: Debt-to-equity is elevated near 3.05. If earnings volatility or higher interest rates pressure the debt servicing profile, management may be forced into more conservative capital allocation, which could limit buybacks or dividends.
- Demand risk: Enterprise IT spending can be lumpy. A macro slowdown or a pull-forward of cloud spend could reduce near-term bookings and extend the recovery timetable.
- Competitive pressure: Hyperscalers and other cloud vendors are aggressive on price and product; if Oracle fails to maintain its cloud execution and pricing power, margin compression could persist.
- Execution risk: Integrating hardware, software and cloud at scale is operationally complex. Missed targets on backlog conversion or product delivery would damage credibility and valuation.
Counterargument: A fair counterargument is that the market's price already reflects the costs of building out a modern, competitive cloud infrastructure at scale. If Oracle's capex program proves structurally necessary to defend share and the company must sustain elevated spending for years, valuations should remain lower than historical software multiples. In that scenario, the investor is not getting a value play but a structurally different, more capital-intensive company.
How this trade will be monitored and what would change my mind
I will watch three datasets closely: quarterly free cash flow and capex cadence, backlog conversion into recurring cloud revenue, and management commentary on pricing and utilization. Positive signs - falling capex, improving free cash flow, and steady backlog conversion - would support adding to the position and keeping the $240 target. Negative signs - another quarter of materially worse-than-expected FCF, worsening leverage metrics, or meaningful churn in cloud contracts - would warrant tightening stops or exiting the position.
Concretely, my view would change if Oracle reports two consecutive quarters showing no improvement in free cash flow and provides guidance implying sustained higher capex beyond the current plan. Conversely, if FCF moves back toward neutral and management confirms backlog realization pacing to revenue, I would raise the target and potentially add to the position.
Conclusion
Oracle's stock has been oversold relative to the underlying business quality. At $159.70, the market appears to be over-penalizing temporary cash-flow stress tied to aggressive data-center investment rather than a permanent degradation in the software franchise. For disciplined, horizon-aware investors, a long trade with a $140 stop and $240 target over 180 trading days offers asymmetric upside: the business still grows, margins remain healthy at the operating level, and a large contracted backlog provides revenue visibility. The trade is not without risks - cash flow and execution are the two biggest - but both are observable and monitorable over the next few quarters. If Oracle begins to show the expected cash-flow recovery, a re-rating becomes a realistic outcome.
Key dates
- 09/10/2026 - Q3 earnings release and management call (watch guidance and capex commentary)
- 07/10/2026 - Most recent ex-dividend date (quarterly dividend $0.50)